ACESION PHARMA
Acesion Pharma is a developer of medical drugs designed for the treatment of atrial fibrillation. The company's medical drugs develop treatments for atrial fibrillation which is the most common type of cardiac arrhythmia by following the concept of inhibiting a type of ion channel in heart cells that is involved in generating the electrical signals that regulate the heart's rhythm, providing consumers with chronic treatment to prevent the recurrence of AF and maintain normal heart rhythm.
ACESION PHARMA
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2011-01-01
Address:
Copenhagen, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.acesionpharma.com
Total Employee:
11+
Status:
Active
Contact:
45 44 64 08 76
Email Addresses:
[email protected]
Total Funding:
67.68 M USD
Technology used in webpage:
Organization Schema Person Schema CrUX Top 50m CrUX Dataset
Similar Organizations
Alchemab Therapeutics
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Buhloncology
Buhloncology develops anticancer drugs and provides strategic and operational leadership.
CLL Pharma S.A
CLL Pharma S.A developer of generic drugs designed to offer galenical formulations.
Ennar Pharma
Development of medicines for the treatment of psoriasis.
Forendo Pharma
Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Sinosi
Sinosi develops a transepicardial chemical ablation device for the treatment of atrial fibrillation.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alpha Wave Global
Alpha Wave Global investment in Series B - Acesion Pharma
Canaan Partners
Canaan Partners investment in Series B - Acesion Pharma
Global BioAccess Fund
Global BioAccess Fund investment in Series B - Acesion Pharma
Novo Holdings
Novo Holdings investment in Series B - Acesion Pharma
Novo Holdings
Novo Holdings investment in Series A - Acesion Pharma
Wellcome Trust
Wellcome Trust investment in Series A - Acesion Pharma
Novo Holdings
Novo Holdings investment in Venture Round - Acesion Pharma
Broadview Ventures
Broadview Ventures investment in Venture Round - Acesion Pharma
Novo Holdings
Novo Holdings investment in Venture Round - Acesion Pharma
Wellcome Trust
Wellcome Trust investment in Venture Round - Acesion Pharma
Official Site Inspections
http://www.acesionpharma.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Acesion Pharma"
Governance | Acesion Pharma
Morten Grunnet, PhD, DrSc, is co-founder, board member and CSO at Acesion Pharma. He brings +15 years of drug discovery experience at director level from both biotech and big …See details»
Home | Acesion Pharma
Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Acesion Pharma develops more efficacious and safe drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia.See details»
About | Acesion Pharma
Acesion Pharma ApS is a Danish biotech company founded in 2011 and based in Copenhagen. Our technology is based on research initiated in 2008 at University of Copenhagen and chemistry insights from the company Neurosearch. …See details»
Acesion Pharma - LinkedIn
Acesion Pharma is a Danish biotech company founded in 2011. We are aiming to develop more efficacious and safer drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac ...See details»
Acesion Pharma - Crunchbase Company Profile
Acesion Pharma may be growing as it has successfully closed an oversubscribed Series B financing round, securing €45 million in funding. This substantial …See details»
Acesion Pharma Overview | SignalHire Company Profile
Its headquarters is located at Copenhagen, Other, DK. The number of employees ranges from 25 to 100. The annual revenue of Acesion Pharma varies between 100K and 5.0M. Total funding …See details»
Acesion Pharma 2025 Company Profile: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Acesion Pharma. Use the PitchBook Platform to explore the full profile.See details»
Acesion Pharma - Products, Competitors, Financials, Employees ...
About Acesion Pharma Acesion Pharma is a Danish biotech company developing drugs for the treatment of atrial fibrillation, a common cardiac arrhythmia. The company creates therapies …See details»
Acesion Pharma Company Profile: Overview and Full News Analysis
Acesion Pharma is a Danish biotech company located in Hovedstaden, founded in 2011 as a spin-out from Neurosearch and the University of Copenhagen. The company's primary focus …See details»
Acesion Pharma CEO, Founder, Key Executive Team, Board of …
Explore {Acesion Pharma's key management people. Discover current leadership team members including founders, CEO, other executives and board directors.See details»
Acesion Pharma Information - RocketReach
Acesion Pharma is a Pharmaceutical Manufacturing, Manufacturing General, and Biotechnology company located in Ballerup, Region Hovedstaden with $1 million in revenue and 18 …See details»
Investors | Acesion Pharma
Novo Holdings is a founding investor in Acesion Pharma and invested in the company through Novo Seeds, the early stage investment arm of Novo Holdings.See details»
Nextsource | Company Profile | Acesion Pharma
Explore the company profile of Acesion Pharma (acesionpharma.com) featuring business details and insights, funding data, industry info, employee numbers, and more.See details»
Acesion Pharma ApS - Drug pipelines, Patents, Clinical trials
Explore Acesion Pharma ApS with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 13 news, and 16 literature, Technology Platform:Small molecule drug, Drug:AP …See details»
Acesion Pharma - Overview, News & Similar companies - ZoomInfo
View Acesion Pharma (www.acesionpharma.com) location in Zealand, Denmark , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Acesion Pharma Closes Oversubscribed €45M Series B Financing …
Sep 26, 2023 Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the Company”), a biotech company pioneering first-in-class novel therapies for atrial fibrillation (“AF”), the most …See details»
Acesion Pharma - 2025 Company Profile - Tracxn
Mar 4, 2025 Acesion Pharma is a biotech company developing drugs for the medical treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The company is …See details»
Acesion Pharma Company Information - Funding, Investors, and …
Get information on funding, investors, industries, and more for Acesion Pharma. See Acesion Pharma company profile and funding data.See details»
Science - Acesion Pharma
Giulia Gatta et al. Effective termination of atrial fibrillation by SK channel inhibition is associated with a sudden organization of fibrillatory conduction. Europace, 2021 Nov 8;23 (11):1847 …See details»
News - Acesion Pharma
May 15, 2023 Copenhagen, Denmark – Acesion Pharma (“Acesion” or “the Company”), a biotech company pioneering first-in-class novel therapies for atrial...See details»